Besides germline mutations, LKB1 can be inactivated by somatic mutations that lead to a predisposition to sporadic cancers such as pancreatic, breast and gastrointestinal cancers, as well as melanoma and especially lung cancer. This evidence concerns the gene STK11 and lung cancer.